Overview


According to FutureWise analysis the market for advanced dermatology drug delivery devices in 2023 is US$ 5.13 billion, and is expected to reach US$ 10.9 billion by 2031 at a CAGR of 9.90%.

Dermatology drug delivery devices refer to innovative technologies and approaches to enhance the administration of medications and treatments for various dermatological conditions. These devices improve the effectiveness, safety, and patient adherence of dermatological therapies. Advanced drug delivery devices have emerged as cutting-edge solutions that enhance the efficacy of therapies and boost patient comfort and compliance. These innovative devices expand the opportunities for precise and targeted delivery of drugs, facilitating the treatment of dermatological conditions varying from common conditions like acne and eczema to more complex concerns such as skin cancer and chronic skin disorders. As technology continues to develop, the dermatology community is increasingly exploring and harnessing the potential of these devices to optimize the delivery of medications and unlock new possibilities in skincare and dermatological care.

Microneedles (MNs) are minimally invasive, micro-sized needle devices that are fabricated from a variety of materials, such as biomaterials, metals, polymers, ceramics, and composites, which are designed to penetrate the skin’s stratum corneum layer for various applications. There are different types of microneedles, including solid microneedles used for skin pretreatment to increase skin permeability, microneedles coated with a drug that dissolves off in the skin, polymer microneedles that encapsulate the drug and completely dissolve in the skin, and hollow microneedles for infusing drugs into the skin. Microneedles aim to deliver bioactive materials, vaccines, and pharmaceutical agents and to collect bio-signals and substances from the body with minimal invasiveness. The administration of drugs through the gastrointestinal passage has not been the most efficient due to the poor absorption of orally ingested drugs and the pharmacokinetic activities of the body, which leaves only a fraction of the drug to reach its intended therapeutic effect.

FutureWise Market Research has published a report that provides an insightful advanced dermatology drug delivery devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, advanced dermatology drug delivery devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • AptarGroup, Inc.
  • Bespak
  • E3D Elcam Drug Delivery Devices
  • Kindeva Drug Delivery L.P.
  • Latch Medical
  • Becton Dickinson and Company
  • Medicsensors S.L.
  • Midas Pharma GmbH.
  • Credence MedSystems, Inc.
  • Nemera
  • Owen Mumford
  • Portal Instruments, Inc.
  • LTS Lohmann Therapie-Systeme AG
  • Vaxxas Inc.
  • West Pharmaceutical Services, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Advanced Dermatology Drug Delivery Devices Market:

  • In October 2022, Emergex Vaccines Holding Ltd bought the assets of Zosano Pharma Corporation of California. The acquired assets include intellectual property, license agreements, and production equipment. In addition, they include Zosano's proprietary microneedle array patch (MAP) intradermal drug delivery system.
     
  • In June 2021, AptarGroup, Inc. acquired Voluntis. The acquisition will aid the company in expanding its presence in digital therapeutics.

The increasing prevalence of dermatological conditions such as acne, eczema, psoriasis, and skin cancer is expected to drive the demand for the advanced dermatology drug delivery devices market. As these conditions affect the growing population, there is a growing demand for innovative drug delivery solutions that provide more effective, targeted, and user-friendly treatment options. In addition, the increasing patient pool, with a desire for improved therapeutic effects, has spurred the development and adoption of advanced drug delivery devices, further propelling the market expansion throughout the forecast period. Moreover, the advancement of telemedicine and e-commerce platforms presents an optimistic opportunity for the advanced dermatological drug delivery devices market. These digital channels allow patients to access dermatological consultations and purchase related products, including drug delivery devices, from the comfort of their homes. This expanded reach broadens the potential customer base. It allows manufacturers and healthcare professionals to offer details, support, and products to individuals in remote or developing areas, further boosting the market growth. Furthermore, the high cost of superior design and scaling up production of microneedles are expected to impede the growth of the advanced dermatology drug delivery devices market during the projection period. Developing creative and superior designs for drug delivery devices requires considerable investment in research & development and testing. This cost may discourage smaller companies from entering the market and limit the availability of cutting-edge technologies. Also, scaling up production to meet market demands often involves more capital investment and operational challenges, which might strain resources and hinder market growth.

By Product Type

  • Injectors
    • Disposable Injectors
    • Reusable Injectors
    • Wearable Injectors
  • Patches
    • Microarray (MAP) Patches
    • Microneedle (MNP) Patches
      • Solid Removable Microneedles
      • Coated Microneedles
      • Dissolving Microneedles
      • Hollow Microneedles
      • Hydrogel-Forming Microneedles
    • Needle-less Patches
  • Airless Dispensers and Bottles
  • Dermal Pumps
  • Valves
  • Other Devices

By Sales Channel

  • B2B Sales (Pharma/Direct)
  • B2C Sales (OTC/Indirect)

By End User

  • Hospitals
  • Dermatology Practices
  • Home Use

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to factors such as the rising incidence of chronic diseases, technologically advanced healthcare systems globally, an increase in the geriatric population, well-established businesses in the area, and a number of early adaptors for advanced dermatology delivery systems in the U.S. are expected to fuel the market growth over the projection period. For instance, in October 2021, AptarGroup, Inc. launched the AdhereIT-connected onboarding solution with Noble International for disease management, adherence, and onboarding patients. Therefore, the above-mentioned factors propel the market growth in the region.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Advanced Dermatology Drug Delivery Devices Market By Product Type, By Sales Channel, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Advanced Dermatology Drug Delivery Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Advanced Dermatology Drug Delivery Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Advanced Dermatology Drug Delivery Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Advanced Dermatology Drug Delivery Devices Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Injectors
         1.1. Disposable Injectors
         1.2. Reusable Injectors
         1.3. Wearable Injectors
        2. Patches
         2.1. Microarray (MAP) Patches
         2.2. Microneedle (MNP) Patches
          2.2.1. Solid Removable Microneedles
          2.2.2. Coated Microneedles
          2.2.3. Dissolving Microneedles
          2.2.4. Hollow Microneedles
          2.2.5. Hydrogel-Forming Microneedles
         2.3. Needle-less Patches
        3. Airless Dispensers and Bottles
        4. Dermal Pumps
        5. Valves
        6. Other Devices

  • 8.   Advanced Dermatology Drug Delivery Devices Market, By Sales Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. B2B Sales (Pharma/Direct)
        2. B2C Sales (OTC/Indirect)

  • 9.   Advanced Dermatology Drug Delivery Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Dermatology Practices
        3. Home Use

  • 10.   North America Advanced Dermatology Drug Delivery Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Advanced Dermatology Drug Delivery Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Advanced Dermatology Drug Delivery Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Advanced Dermatology Drug Delivery Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. AptarGroup, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bespak
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. E3D Elcam Drug Delivery Devices
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Kindeva Drug Delivery L.P.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Latch Medical
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Becton Dickinson and Company
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medicsensors S.L.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Midas Pharma GmbH.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Credence MedSystems, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Nemera
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Owen Mumford
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Portal Instruments, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. LTS Lohmann Therapie-Systeme AG
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Vaxxas Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. West Pharmaceutical Services, Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Prescription Dermatological Drugs Market

Read More
Partner

Our Clients